Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -244,260 | -131,556 | -6,687 | -109,681 | -2,675 |
| Depreciation Amortization | 304,484 | 161,757 | 17,993 | 185,794 | 67,496 |
| Income taxes - deferred | -28,493 | -11,460 | -1,060 | -15,513 | -7,508 |
| Accounts receivable | 22,722 | -11,561 | -378 | -17,041 | -33,821 |
| Accounts payable and accrued liabilities | -14,964 | -5,953 | -4,279 | -11,326 | -9,063 |
| Other Working Capital | -3,585 | -25,948 | -17,834 | -25,857 | -50,120 |
| Other Operating Activity | -3,012 | 20,562 | 6,118 | 31,182 | 42,864 |
| Operating Cash Flow | $32,892 | $-4,159 | $-6,127 | $37,558 | $7,174 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,030 | -2,091 | -635 | -4,134 | -2,988 |
| Net Acquisitions | -34 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-3,064 | $-2,091 | $-635 | $-4,134 | $-2,988 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,314 | 1,314 | N/A | 2,745 | 975 |
| Debt Repayment | -2,788 | -2,161 | -1,010 | -57,223 | -6,706 |
| Common Stock Issued | N/A | N/A | N/A | 58,084 | N/A |
| Common Stock Repurchased | -1,338 | 0 | 0 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -2 | -2 |
| Financing Cash Flow | $-2,812 | $-847 | $-1,010 | $3,604 | $-5,734 |
| Exchange Rate Effect | 164 | N/A | N/A | -938 | -993 |
| Beginning Cash Position | 70,834 | 70,834 | 70,834 | 34,744 | 34,743 |
| End Cash Position | 98,014 | 63,737 | 63,062 | 70,834 | 32,203 |
| Net Cash Flow | $27,180 | $-7,097 | $-7,772 | $36,090 | $-2,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,892 | -4,159 | -6,127 | 37,558 | 7,174 |
| Capital Expenditure | -3,042 | -2,091 | -635 | -4,144 | -2,998 |
| Free Cash Flow | 29,850 | -6,250 | -6,762 | 33,414 | 4,176 |